Farm Animal Drugs Market Report 2026

Farm Animal Drugs Market Overview

• Farm Animal Drugs market size has reached to $20.66 billion in 2025 • Expected to grow to $28.88 billion in 2030 at a compound annual growth rate (CAGR) of 7.1% • Growth Driver: Rising Meat Consumption Fuels Growth In The Farm Animal Drug Market • Market Trend: Innovative Solutions For Cattle Parasite Control • Asia-Pacific was the largest region in 2025.

What Is Covered Under Farm Animal Drugs Market?

Farm animal drugs refer to medications specifically designed for the treatment, prevention, and control of diseases in livestock, such as cattle, pigs, and poultry. These drugs are used to ensure animal health, improve productivity, and prevent the spread of infections. They are essential for maintaining food safety and meeting veterinary health standards in farming operations. The main products of farm animal drugs are anti-infective, parasiticides, anti-inflammatory, anesthetics, analgesics, hormones, and related products, and others. Anti-infective refers to an agent with the ability to fight infection by either preventing the spread of an infectious agent or by destroying the infectious pathogen to treat severe infections, anti-infective medication is helpful in equine or small animal treatment. These are administered through oral, parenteral, topical, and other routes and can be distributed through veterinary hospitals, veterinary clinics, pharmacies, drug stores, and others for various animals including livestock animals and equine.

What Is The Farm Animal Drugs Market Growth Forecast?

The farm animal drugs market size is expected to see strong growth in the next few years. It will grow to $28.88 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rising emphasis on antimicrobial stewardship, increasing demand for high-quality animal protein, growth in veterinary healthcare infrastructure, stricter food safety and animal welfare regulations, innovation in livestock-specific drug formulations. Major trends in the forecast period include rising demand for preventive veterinary medications, increasing use of combination drug therapies, growing focus on food safety and residue compliance, expansion of therapeutics for intensive livestock farming, increasing adoption of prescription-based veterinary drugs.

Global Farm Animal Drugs Market Segmentation

1) By Product: Anti-Infective, Parasiticides, Anti-Inflammatory, Anesthetics, Analgesics, Hormones And Related Product, Other Products 2) By Route Of Administration: Oral, Parenteral, Topical, Other Route Of Administrations 3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels 4) By Animal: Livestock Animals, Equine Subsegments: 1) By Anti-Infective: Antibiotics, Antivirals, Antifungals 2) By Parasiticides: Endectocides, Anthelmintics, Ectoparasiticides 3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids 4) By Anesthetics: Local Anesthetics, General Anesthetics 5) By Analgesics: Opioids, Non-Opioid Analgesics 6) By Hormones And Related Products: Reproductive Hormones, Growth Promoters, Thyroid Hormones 7) By Other Products: Vaccines, Nutraceuticals, Diagnostic Products

What Is The Driver Of The Farm Animal Drugs Market?

The increasing meat consumption is expected to propel the growth of the farm animal drug market going forward. Meat consumption refers to eating animal flesh as a food source. It is commonly made from livestock like chickens, pigs, or cattle. Farm animal drugs speed up animal development and improve how food becomes meat. The increasing meat consumption is rising due to the growing global population and urbanization, which leads to higher demand for protein-rich food sources as people have more access to and preference for meat in their diets. The farm animal drug market supports the increasing meat consumption, as the rising demand for meat drives the need for veterinary drugs to ensure the health and productivity of livestock, improving meat quality and supply. For instance, in July 2025, according to the Department for Environment, Food and Rural Affairs (Defra), a UK-based government department, total UK meat production in 2024 was 4,166 thousand tonnes, up from 4,059 thousand tonnes in 2023. Therefore, the increasing meat consumption is driving the growth of the farm animal drug industry.

Key Players In The Global Farm Animal Drugs Market

Major companies operating in the farm animal drugs market are Eli Lilly and Company, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Hester Biosciences Limited, Ceva Santé Animale SA, Virbac SA, Huvepharma Inc, Phibro Animal Health Corporation, Dechra Pharmaceuticals plc, Laboratorios Hipra S.A., Norbrook Laboratories Ltd., Neogen Corporation, Ouro Fino Saude Animal Participacoes SA, Eco Animal Health Ltd, Biogenesis Bago SA, Laboratorios Calier S.A., Laboratorios Syva S.A., Jurox Pty Ltd, Kepro B.V., Kyoritsu Seiyaku Corp., Merck Animal Health, Vetoquinol SA, Nippon Zenyaku Kogyo Co. Ltd., SeQuent Scientific Limited, Agrovet Market Animal Health, Orion Pharma Animal Health, Zydus Animal Health and Investments Limited

Global Farm Animal Drugs Market Trends and Insights

Major companies in the farm animal drugs market are focused on developing innovative solutions, such as moxidectin injectable solutions, for cattle parasite control and maximize their profits in the market. Moxidectin injectable solution is an antiparasitic drug delivered in liquid form for the treatment and control of internal and external parasites in cattle. For instance, in March 2023, Norbrook Laboratories Ltd., a UK-based pharmaceutical company, received FDA approval for Tauramox, the first generic moxidectin injectable solution for the treatment and control of internal and external parasites in beef and nonlactating dairy cattle. Tauramox has the same concentration as moxidectin. Available over the counter, Tauramox is supplied in 10 mg/ml concentration in 250-ml and 500-mL bottles, with a recommended administration rate of 1 mL for each 110 lb body weight.

What Are Latest Mergers And Acquisitions In The Farm Animal Drugs Market?

In July 2024, MSD Animal Health, a US-based provider of veterinary pharmaceuticals, vaccines, health management solutions and animal health technologies, acquired Elanco Animal Health Incorporated’s aqua business for an undisclosed amount. With this acquisition, Merck Animal Health aimed to expand its product portfolio and strengthen its position in the global aquaculture market by adding a comprehensive range of fish health and sustainability solutions, including vaccines, anti-parasitic treatments, nutritionals and related technologies. Elanco Animal Health Incorporated is a US-based provider of health products and solutions for aquatic species, including warm-water and cold-water vaccines, treatments and supplements for fish health management.

Regional Outlook

Asia-Pacific was the largest region in the farm animal drugs market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Farm Animal Drugs Market?

The farm animal drugs market consists of sales of endo-parasiticides, ectoparasitic ides, and endectocides. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.